FDA says single-dose shot from J&J prevents severe COVID
Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.
States rush to catch up on delayed vaccines, expand access
HOUSTON (AP) — A giant vaccination center is opening in Houston to administer 126,000 coronavirus doses in the next three weeks. Nevada health officials are working overtime to distribute delayed shots. And Rhode Island is rescheduling appointments after a vaccine shipment failed to arrive as scheduled earlier in the week.
Half a million dead in US, confirming virus’s tragic reach
For weeks after Cindy Pollock began planting tiny flags across her yard — one for each of the more than 1,800 Idahoans killed by COVID-19 — the toll was mostly a number. Until two women she had never met rang her doorbell in tears, seeking a place to mourn the husband and father they had just lost.
First Test for All Known Human Coronaviruses, Including SARS-CoV-2 Variants
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2. The research is published in Communications Biology, a Nature journal.
Thousands of service members saying no to COVID-19 vaccine
By the thousands, U.S. service members are refusing or putting off the COVID-19 vaccine as frustrated commanders scramble to knock down internet rumors and find the right pitch that will persuade troops to get the shot.
